Marcus Remmers
Direktor/Vorstandsmitglied bei Invetx, Inc.
Profil
Marcus Remmers is currently working as a Director at Invetx, Inc. and as a Partner at Novo Holdings AS (Denmark).
He has an undergraduate degree from the University of Freiburg and another undergraduate degree from the University of Münster.
Aktive Positionen von Marcus Remmers
| Unternehmen | Position | Beginn |
|---|---|---|
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Corporate Officer/Principal | - |
Invetx, Inc.
 Invetx, Inc. Medical SpecialtiesHealth Technology Invetx, Inc. operates as a veterinary therapeutics company. It focuses on biopharmaceuticals that bring human biotechnology to animal health. The company is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 26.06.2023 |
Ausbildung von Marcus Remmers
| University of Freiburg | Undergraduate Degree |
| University of Münster | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Finance |
Invetx, Inc.
Invetx, Inc. Medical SpecialtiesHealth Technology Invetx, Inc. operates as a veterinary therapeutics company. It focuses on biopharmaceuticals that bring human biotechnology to animal health. The company is headquartered in Boston, MA. | Health Technology |
